Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 354143, 8 pages
http://dx.doi.org/10.1155/2015/354143
Review Article

Natural Compounds Regulate Glycolysis in Hypoxic Tumor Microenvironment

Zhejiang Chinese Medical University, No. 548 Binwen Road, Binjiang District, Hangzhou, Zhejiang 310053, China

Received 22 August 2014; Accepted 1 October 2014

Academic Editor: Ying-Bo Li

Copyright © 2015 Jian-Li Gao and Ying-Ge Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. G. V. Heiden, L. C. Cantley, and C. B. Thompson, “Understanding the warburg effect: the metabolic requirements of cell proliferation,” Science, vol. 324, no. 5930, pp. 1029–1033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Chen, J. Xie, Z. Jiang, B. Wang, Y. Wang, and X. Hu, “Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2,” Oncogene, vol. 30, no. 42, pp. 4297–4306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. B. Park, “Flavonoids are potential inhibitors of glucose uptake in U937 cells,” Biochemical and Biophysical Research Communications, vol. 260, no. 2, pp. 568–574, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Nomura, T. Takahashi, N. Nagata et al., “Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells,” Biological and Pharmaceutical Bulletin, vol. 31, no. 7, pp. 1403–1409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Vaughan, R. Garcia-Smith, J. Dorsey, J. K. Griffith, M. Bisoffi, and K. A. Trujillo, “Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells,” International Journal of Cancer, vol. 133, no. 10, pp. 2504–2510, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Pérez, P. Ojeda, L. Ojeda et al., “Hexose transporter GLUT1 harbors several distinct regulatory binding sites for flavones and tyrphostins,” Biochemistry, vol. 50, no. 41, pp. 8834–8845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. P. Torres, S. Rachagani, V. Purohit et al., “Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism,” Cancer Letters, vol. 323, no. 1, pp. 29–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Liu, C. K. Venna, J. B. Morgan et al., “Methylalpinumisoflavone inhibits hypoxia-inducible factor-1 (HIF-1) activation by simultaneously targeting multiple pathways,” Journal of Biological Chemistry, vol. 284, no. 9, pp. 5859–5868, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Cohen and E. Flescher, “Methyl jasmonate: a plant stress hormone as an anti-cancer drug,” Phytochemistry, vol. 70, no. 13-14, pp. 1600–1609, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Deng, X. Yu, L. Xiao et al., “Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway,” Cell Death and Disease, vol. 4, no. 9, article e804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Liu, N. Wu, L. Ma et al., “Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms,” PLoS ONE, vol. 9, no. 3, Article ID e91606, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. T.-X. Wang, X.-Y. Shi, Y. Cong, Z.-Q. Zhang, and Y.-H. Liu, “Prosapogenin A inhibits cell growth of MCF7 via downregulating STAT3 and glycometabolism-related gene,” Yao Xue Xue Bao, vol. 48, no. 9, pp. 1510–1514, 2013. View at Google Scholar · View at Scopus
  14. C. Xing, J. R. LaPorte, J. K. Barbay, and A. G. Myers, “Identification of GAPDH as a protein target of the saframycin antiproliferative agents,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 16, pp. 5862–5866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Li, J. Liu, K. Jackson, R. Shi, and Y. Zhao, “Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells,” PLoS ONE, vol. 9, no. 4, Article ID e94079, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Wang, D. Wang, S. Han et al., “Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer,” PLoS ONE, vol. 8, no. 2, Article ID e56631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Pathania, M. Millard, and N. Neamati, “Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism,” Advanced Drug Delivery Reviews, vol. 61, no. 14, pp. 1250–1275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Anastasiou, Y. Yu, W. J. Israelsen et al., “Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis,” Nature Chemical Biology, vol. 8, no. 10, pp. 839–847, 2012. View at Publisher · View at Google Scholar
  19. M. G. Vander Heiden, H. R. Christofk, E. Schuman et al., “Identification of small molecule inhibitors of pyruvate kinase M2,” Biochemical Pharmacology, vol. 79, no. 8, pp. 1118–1124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Kolev, H. Uetake, Y. Takagi, and K. Sugihara, “Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1α) pathway, angiogenic factors production and poor prognosis,” Annals of Surgical Oncology, vol. 15, no. 8, pp. 2336–2344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Xie, V. A. Valera, M. J. Merino et al., “LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer,” Molecular Cancer Therapeutics, vol. 8, no. 3, pp. 626–635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. Z.-Y. Wang, T. Y. Loo, J.-G. Shen et al., “LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis,” Breast Cancer Research and Treatment, vol. 131, no. 3, pp. 791–800, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. V. R. Fantin, J. St-Pierre, and P. Leder, “Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance,” Cancer Cell, vol. 9, no. 6, pp. 425–434, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Zhong, Y. Dang, X. Yuan et al., “Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo,” Cellular Physiology and Biochemistry, vol. 30, no. 3, pp. 778–790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Qian, T. Guan, X. Tang et al., “Maslinic acid, a natural triterpenoid compound from Olea europaea, protects cortical neurons against oxygen-glucose deprivation-induced injury,” European Journal of Pharmacology, vol. 670, no. 1, pp. 148–153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Abu-Remaileh and R. I. Aqeilan, “Tumor suppressor WWOX regulates glucose metabolism via HIF1α modulation,” Cell Death and Differentiation, vol. 21, no. 11, pp. 1805–1814, 2014. View at Google Scholar
  27. C. Zhang, J. Liu, Y. Liang et al., “Tumour-associated mutant p53 drives the Warburg effect,” Nature Communications, vol. 4, article 2935, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Kurabayashi, Y. Kakinuma, T. Morita, K. Inoue, T. Sato, and M. Furihata, “Conditional VHL gene deletion causes hypoglycemic death associated with disproportionately increased glucose uptake by hepatocytes through an upregulated IGF-I receptor,” PLoS ONE, vol. 8, no. 7, Article ID e69139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. D. G. Nagle and Y.-D. Zhou, “Marine natural products as inhibitors of hypoxic signaling in tumors,” Phytochemistry Reviews, vol. 8, no. 2, pp. 415–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Chen, Y. Liu, S. Wang et al., “Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2,” Pharmacogenomics, vol. 14, no. 11, pp. 1305–1317, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. Y.-D. Zhou, Y.-P. Kim, K. A. Mohammed et al., “Terpenoid tetrahydroisoquinoline alkaloids emetine, klugine, and isocephaeline inhibit the activation of hypoxia-inducible factor-1 in breast tumor cells,” Journal of Natural Products, vol. 68, no. 6, pp. 947–950, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. T. W. Hodges, C. F. Hossain, Y.-P. Kim, Y.-D. Zhou, and D. G. Nagle, “Molecular-targeted antitumor agents: The Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1,” Journal of Natural Products, vol. 67, no. 5, pp. 767–771, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Mylonis, A. Lakka, A. Tsakalof, and G. Simos, “The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions,” Biochemical and Biophysical Research Communications, vol. 398, no. 1, pp. 74–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. V. E. Fernand, J. N. Losso, R. E. Truax et al., “Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro,” Chemico-Biological Interactions, vol. 192, no. 3, pp. 220–232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M.-H. Li, Z.-H. Miao, W.-F. Tan et al., “Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1α by promoting proteasome-mediated degradation,” Clinical Cancer Research, vol. 10, no. 24, pp. 8266–8274, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Yum, H.-J. Doh, S. Hong et al., “Piceatannol, a hydroxystilbene natural product, stabilizes HIF-1α protein by inhibiting HIF prolyl hydroxylase,” European Journal of Pharmacology, vol. 699, no. 1–3, pp. 124–131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Hattori, K. Okuda, T. Murase et al., “Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis,” Bioorganic and Medicinal Chemistry, vol. 19, no. 18, pp. 5392–5401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Shu, X. Mi, J. Cai et al., “Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway,” Toxicology Letters, vol. 222, no. 2, pp. 91–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Madan, R. Gogna, M. Bhatt, U. Pati, P. Kuppusamy, and A. A. Mahdi, “Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor,” Oncotarget, vol. 2, no. 12, pp. 948–957, 2011. View at Google Scholar · View at Scopus
  40. M. Nepal, H. Jung Choi, B.-Y. Choi et al., “Anti-angiogenic and anti-tumor activity of Bavachinin by targeting hypoxia-inducible factor-1α,” European Journal of Pharmacology, vol. 691, no. 1–3, pp. 28–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. G. M. Woldemichael, T. J. Turbyville, W. M. Linehan, and J. B. McMahon, “Carminomycin I is an apoptosis inducer that targets the golgi complex in clear cell renal carcinoma cells,” Cancer Research, vol. 71, no. 1, pp. 134–142, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. W.-S. Lin, G.-Y. Lu, S.-M. Huang, S.-T. Liu, P.-Y. Liu, and W.-Y. Chou, “Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes,” The International Journal of Biochemistry & Cell Biology, vol. 47, no. 1, pp. 83–92, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Wang, L. Zhao, L.-T. Zhu et al., “Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway,” Molecular Carcinogenesis, vol. 53, no. 1, pp. E107–E118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Zhao, X. Song, Y. Huang et al., “Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling,” European Journal of Pharmacology, vol. 737, pp. 57–69, 2014. View at Publisher · View at Google Scholar
  45. B. Faubert, G. Boily, S. Izreig et al., “AMPK is a negative regulator of the warburg effect and suppresses tumor growth in vivo,” Cell Metabolism, vol. 17, no. 1, pp. 113–124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. K. R. Laderoute, J. M. Calaoagan, W. R. Chao et al., “5′-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumors,” The Journal of Biological Chemistry, vol. 289, no. 33, pp. 22850–22864, 2014. View at Publisher · View at Google Scholar
  47. T. A. D. Smith, M. Zanda, and I. N. Fleming, “Hypoxia stimulates 18F-fluorodeoxyglucose uptake in breast cancer cells via hypoxia inducible factor-1 and AMP-activated protein kinase,” Nuclear Medicine and Biology, vol. 40, no. 6, pp. 858–864, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Liu, L. Zheng, N. Wu et al., “Oleanolic acid induces metabolic adaptation in cancer cells by activating the AMP-activated protein kinase pathway,” Journal of Agricultural and Food Chemistry, vol. 62, no. 24, pp. 5528–5537, 2014. View at Publisher · View at Google Scholar
  49. Y. Liu, Y. Cao, W. Zhang et al., “A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo,” Molecular Cancer Therapeutics, vol. 11, no. 8, pp. 1672–1682, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Dando, M. Donadelli, C. Costanzo et al., “Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells,” Cell Death and Disease, vol. 4, no. 6, article e664, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. Z. Li, X. Li, S. Wu, M. Xue, and W. Chen, “Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway,” Cancer Science, vol. 105, no. 8, pp. 951–955, 2014. View at Publisher · View at Google Scholar